A2a antagonists (Gilead Palo Alto)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameA2a antagonists (Gilead Palo Alto)
Drug Alias NameA2a antagonists (CV Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine A2a receptor antagonists
TargetsAdenosine A2a receptor
Therapy Area/IndicationsSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Palo Alto Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Palo Alto Inc
Active IndicationsN/A
Inactive IndicationsSubstance-Related Disorders

Other Information

ATC CodeN/A
Related LinksN/A